Skip to content

CROI: Integrase inhibitor raltegravir (MK-0518) doubles HIV suppression in treatment-experienced patients at 16 weeks

CROI: Non-AIDS malignancies now more common than AIDS-defining cancers in people with HIV

Scientific evidence alone cannot prove liability in criminal HIV transmission cases

CROI: HIV treatment should not be delayed in TB patients with low CD4 counts, South African study shows

CROI: Women infected with HIV subtype D progress faster despite same viral load

CROI: MSF reports good responses on PI-based second-line ART regimens even though switch from failing regimens comes late

CROI: Tenofovir microbicide stops rectal infection in monkeys better than PrEP

CROI: Growth hormone stimulant TH9507 safe and effective in HIV lipodystrophy

CROI: Alendronate effectively treats bone loss in men and women with HIV